簡(jiǎn)要描述:核自身抗原SP140抗體免 疫 原;KLH conjugated synthetic peptide derived from mouse SP140: 201-300/534
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
核自身抗原SP140抗體
產(chǎn)品名稱 | 英文名稱 | 貨號(hào) |
核自身抗原SP140抗體 | SP140 | GOY-01K5227 |
商品屬性:
英文名稱: SP140
中文名:核自身抗原SP140抗體
別 名;LY10_MOUSE;
Lymphoid restricted homolog of Sp100; Lymphoid specific SP100 homolog;
Lymphoid-restricted homolog of Sp100; LYSP100 A; LYSp100; LYSP100 B; LYSp100
protein; LYSP100-A; LYSP100-B; LYSP100A; LYSP100B; MGC126440; Nuclear antigen
Sp140; Nuclear autoantigen Sp-140; Nuclear autoantigen Sp140; Nuclear body
protein SP140; SP140; SP140 nuclear body protein; SP140 PEN; Speckled 140 kDa.
研究領(lǐng)域;細(xì)胞生物 轉(zhuǎn)錄調(diào)節(jié)因子 淋巴細(xì)胞 表觀遺傳學(xué)
抗體來(lái)源;Rabbit
克隆類型;Polyclonal
交叉反應(yīng); Mouse,
產(chǎn)品應(yīng)用;ELISA=1:5000-10000
IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;20kDa
細(xì)胞定位;細(xì)胞核 細(xì)胞漿
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from mouse SP140: 201-300/534
亞 型;IgG
純化方法;affinity
purified by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項(xiàng);This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
SP140 is an 867 amino acid cytoplasmic and nuclear
protein that is highly expressed in spleen and peripheral blood leukocytes.
SP140 is a component of the nuclear body that may be involved in trafficking
between the nucleus and the cytoplasm. SP140 is induced by interferons and
contains a bromo domain, a HSR domain, a PHD-type zinc finger and a SAND
domain. It is thought that SP140 may participate in the pathogenesis of acute
promyelocytic leukemia and viral infection. SP140 is expressed as three
isoforms produced by alternative splicing and are designated isoform
LYSp100-A, isoform LYSp100-B and isoform SP140. Component of the nuclear body, also known as
nuclear domain 10, PML oncogenic domain, and KR body. May be involved in the
pathogenesis of acute promyelocytic leukemia and viral infection. |
多克隆抗體制備:
我公司合成抗原,保證陽(yáng)性血清和抗體ELISA效價(jià)達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測(cè)結(jié)果是陽(yáng)性。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項(xiàng)目實(shí)際需求情況靈活選擇進(jìn)行,我公司將為您的項(xiàng)目提供專業(yè)的建議。在制備過(guò)程中,與客戶互動(dòng)驗(yàn)證,確保最終制備的抗體ELISA陽(yáng)性血清檢測(cè)達(dá)到合同要求的同時(shí),也能滿足客戶抗體最終應(yīng)用驗(yàn)證需求。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
重組抗體表達(dá)服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無(wú)法做到的。我公司已搭建好的抗體測(cè)序、重組抗體表達(dá)等先進(jìn)平臺(tái),能為客戶提供各種類型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。
單項(xiàng)免疫學(xué)及檢測(cè)服務(wù):
我公司也為客戶提供單項(xiàng)免疫學(xué)和檢測(cè)服務(wù),如動(dòng)物免疫、動(dòng)物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測(cè)服務(wù)。
抗體定制服務(wù):
已注冊(cè)商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開(kāi)發(fā),是我公司針對(duì)有特定應(yīng)用要求和各種模型測(cè)試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關(guān)注我們的微信了解更多信息
電話
微信掃一掃